Eyenovia Insiders Enjoying US$200k Appreciation On US$1.34m Investment
Eyenovia Shares Are Trading Higher. The Company Announced That It Commenced Activities With NovaBay Pharmaceuticals to Promote Eye Care Products to Ophthalmic Surgery Centers.
Eyenovia Shares Are Trading Higher. The Company Announced That It Commenced Activities With NovaBay Pharmaceuticals to Promote Eye Care Products to Ophthalmic Surgery Centers.
Eyenovia Announces Share Offering and Warrants Sale
NovaBay and Eyenovia Begin Co-Promotion of Eyecare Products to Ophthalmic Surgery Centers
NovaBay Pharmaceuticals, Inc. (NYSE:NBY), a company developing and commercializing high-quality eyecare products, and Eyenovia, Inc. (NASDAQ:EYEN), a commercial-stage ophthalmic company with two FDA-a
Eyenovia Prices $5M Registered Direct Offering Of 7,575,757 Shares And Warrants At $0.66 Per Share And Accompanying Warrant
Eyenovia Prices $5M Registered Direct Offering Of 7,575,757 Shares And Warrants At $0.66 Per Share And Accompanying Warrant
Express News | Eyenovia Announces Pricing of $5M Registered Direct Offering
12 Health Care Stocks Moving In Friday's After-Market Session
GainersLiquidia (NASDAQ:LQDA) stock rose 12.7% to $14.5 during Friday's after-market session. The market value of their outstanding shares is at $1.1 billion. Adagene (NASDAQ:ADAG) shares moved upward
All You Need to Know About Eyenovia (EYEN) Rating Upgrade to Buy
Earnings Call Summary | Eyenovia(EYEN.US) Q1 2024 Earnings Conference
The following is a summary of the Eyenovia, Inc. (EYEN) Q1 2024 Earnings Call Transcript:Financial Performance:Eyenovia reported a Q1 2024 net loss of about $10.9 million or $0.23 per share. This incl
Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fluent Inc (NASDAQ:FLNT) fell sharply during Thursday's session after posting weaker-than-expected quarterly results.Fluent posted adjusted loss of 30 cents per share, versus market expectat
SYTA, DATS and CYN Among Mid-day Movers
Analysts Offer Insights on Healthcare Companies: Eyenovia (EYEN), Alpine Immune Sciences (ALPN) and GoodRx Holdings (GDRX)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersLucy Scientific Discovery (NASDAQ:LSDI) stock moved upwards by 123.5% to $1.14 during Thursday's pre-market session. The market value of their outstanding shares is at $2.0 million. SINTX Techs
HC Wainwright & Co. : The Eynovia (EYEN.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $12.00.
HC Wainwright & Co. : The Eynovia (EYEN.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $12.00.
HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
HC Wainwright & Co. analyst Matthew Caufield reiterates Eyenovia (NASDAQ:EYEN) with a Buy and maintains $12 price target.
Eyenovia Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 1248.31% HC Wainwright & Co. → $12 Reiterates Buy → Buy 03/19/2024 1248.31% HC Wainwright & Co.
Eyenovia Inc (EYEN) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...
Eyenovia Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.
Eyenovia Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.
Eyenovia | 10-Q: Quarterly report
Eyenovia Provides Updates On Its Myopia Phase III Program And Its 2 FDA Approved Commercial Products, Mydcombi And Clobetasol
Remains on track towards accelerating development of its late-stage product candidate in the multi-billion-dollar pediatric progressive myopia market, MicroPinePreparing for a 3Q 2024 launch of the fi